TrialScientific reports2021

A novel multi-biomarker combination predicting relapse from long-term remission after discontinuation of biological drugs in rheumatoid arthritis.

Katsuya Nagatani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.